Regional Variation in Unmet Need for Metabolic Surgery in England: a Retrospective, Multicohort Analysis.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
01 2021
Historique:
received: 29 06 2020
accepted: 22 07 2020
revised: 18 07 2020
pubmed: 5 8 2020
medline: 20 4 2021
entrez: 5 8 2020
Statut: ppublish

Résumé

Metabolic surgery provision is severely limited despite extensive supportive trial evidence. This study estimated the eligible population and the unmet need for metabolic surgery within English regions. Health Survey for England, National Diabetes Audit and population estimates were used to estimate the metabolic surgery eligible population by English region. Hospital Episode Statistics data was examined for metabolic surgery procedure volume by region (2013-2019). Regression analysis examined factors associated with metabolic surgery eligibility. 7.3% of the English population is potentially eligible for metabolic surgery; equivalent to 3.21 million people. Only 0.20% of the eligible English population receive metabolic surgery per year (regional variation 0.08-0.41%). The metabolic surgery eligible population was more likely to be female, older, have fewer educational qualifications and live in more deprived areas.

Identifiants

pubmed: 32748201
doi: 10.1007/s11695-020-04874-w
pii: 10.1007/s11695-020-04874-w
pmc: PMC7398604
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

439-444

Références

Surg Obes Relat Dis. 2018 Mar;14(3):376-380
pubmed: 29254687
Int J Epidemiol. 2012 Dec;41(6):1585-93
pubmed: 22253315
Surg Endosc. 2020 May;34(5):2136-2142
pubmed: 31363893
Lancet Diabetes Endocrinol. 2020 Jul;8(7):640-648
pubmed: 32386567
BMJ. 2010 Aug 26;341:c4296
pubmed: 20798224
Obes Surg. 2015 Aug;25(8):1408-16
pubmed: 25528567
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
J Am Coll Cardiol. 2018 Feb 13;71(6):670-687
pubmed: 29420964
Obes Surg. 2020 Aug;30(8):3201-3207
pubmed: 32440778
Lancet Diabetes Endocrinol. 2020 May;8(5):447-455
pubmed: 32333880
BMJ. 2011 Aug 16;343:d4836
pubmed: 21846714
BJS Open. 2017 Oct 26;1(4):122-127
pubmed: 29951614
Lancet Diabetes Endocrinol. 2020 May;8(5):363-365
pubmed: 32142624

Auteurs

Andrew C Currie (AC)

Department of Metabolic Surgery, St Richard's Hospital, Chichester, UK. andrew.currie@nhs.net.

Alan Askari (A)

Department of Upper GI Surgery, Watford General Hospital, Watford, UK.

Richard C Newton (RC)

Department of Metabolic Surgery, St Richard's Hospital, Chichester, UK.

Lorraine Albon (L)

Department of Bariatric Medicine, St Richard's Hospital, Chichester, UK.

William Hawkins (W)

Department of Metabolic Surgery, St Richard's Hospital, Chichester, UK.

Guy Slater (G)

Department of Metabolic Surgery, St Richard's Hospital, Chichester, UK.

Christopher M Pring (CM)

Department of Metabolic Surgery, St Richard's Hospital, Chichester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH